Trial Profile
A Multicenter Study to Evaluate the Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 05 Jun 2023
Price :
$35
*
At a glance
- Drugs Human adipose-derived somatic cell therapy Bonus BioGroup (Primary)
- Indications Bone disorders
- Focus Adverse reactions
- Sponsors Bonus BioGroup
- 30 Jun 2021 Planned number of patients changed from 10 to 20.
- 30 Jun 2021 Planned End Date changed from 1 Dec 2019 to 1 Sep 2022.
- 30 Jun 2021 Planned primary completion date changed from 1 Sep 2019 to 1 Jun 2022.